company listed its 2024 priorities, and you take it as " they are going to deliver ".... maybe need to reconsider what the announcement actually says.
we all know MSB does not need a bioreactor to treat 300 kids, and even if they instantly achieve 100% market penetration the day after approval, they still dont need it, you claim they don't have 3d now, but you have absolutely no clue.
FDA inspected the 2D manufacturing, so manufacturing will start with the approved 2d process... school adjourned.
MSB Price at posting:
48.0¢ Sentiment: Buy Disclosure: Held
(20min delay)